Baudax Bio, Inc. Profile Avatar - Palmy Investing

Baudax Bio, Inc.

Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-N…

Biotechnology
US, Malvern [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Baudax Bio, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Baudax Bio, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Baudax Bio, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of BXRX's Analysis
CIK: 1780097 CUSIP: 07160F206 ISIN: US07160F4046 LEI: - UEI: -
Secondary Listings
BXRX has no secondary listings inside our databases.